ZURA
Zura Bio Ltd
$5.08
-0.28 (-5.22%)
At close · Jul 7
Market Cap
$509.19M
Shares
94,997,710
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.08
Open$5.36
Day$4.93–5.50
52W$1.08–7.44
Avg vol 30d1.3M
Short int5.9M · 6.2% float · 5.4d
Short vol80%
Last earningsMay 7, 2026
DataMar 2023–Jul 2026
Filing10-Q · May 7
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Weak
Sentiment
Bullish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+6%
above
Price vs 50-day avg
+13%
above
RSI (14)
57
neutral
MACD trend
Positive
52-week position
63%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+49%
trailing
6-month return
−2%
trailing
YTD return
−3%
this year
Relative strength
−9%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $5 — 200d above 50d
Institutional flow
Accumulating
+26% holders QoQ · +31 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
6.18% of float · ▼ -5.6% MoM · 5.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
93 holders — near 3-yr high, broad support
Squeeze score
57
elevated · 0–100
Fundamentals
EPS growth
−77%
Y/Y
Free cash flow
$-64.9M
Balance sheet
$109.4M
net cash
Quant / Vol
risk profile
Volatility
112%
annualized · 1-yr
Max drawdown
−52%
past year
ATR
8.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Aug 10, 2026
Est · unconfirmed
· in 5 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+6%
Bullish
Price vs 50-day avg
+13%
Bullish
RSI (14)
57
Neutral
MACD trend
Positive
Bullish
52-week position
63%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $4 › 200d $5 — 200d above 50d
Institutional flow
Accumulating
+26% holders QoQ · +31 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
6.18% of float · ▼ -5.6% MoM · 5.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
93 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $1
Now $5 · 63%
52-wk high $7
vs 200-day avg +6%
vs 50-day avg +13%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ZURA
this stock
Zura Bio Ltd
|
$509.19M | -3.1% | — | — | 6.2% |
|
ONC
BeOne Medicines Ltd.
|
$446.53B | +1.7% | +22179.2% | 908.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$132.55B | +15.2% | +46.2% | 31.0 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.90B | -12.3% | +20.8% | 16.5 | 3.2% |
|
ARGX
Argenx SE
|
$57.49B | +9.4% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ZURA | -2.3% | +49.4% | -1.6% | -13.9% | -3.1% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | -3.2% | +48.0% | -9.1% | -14.0% | -12.7% |